Department of
Obstetrics and Gynecology

UNIVERSITY OF WISCONSIN
SCHOOL OF MEDICINE AND PUBLIC HEALTH
Portrait

Stephen L. Rose, MD
Professor (CHS)
Director, Division of Gynecologic Oncology

Gynecologic Oncology



Office Address
UW Hospital and Clinics, Room: H4-650
600 Highland Ave
Madison, WI, 53705


Administrative Assistant
Cortney Wood
cwood3@wisc.edu
(608) 263-1210

Education

B.S. Butler University, Indianapolis, IN
M.D. Indiana University School of Medicine , Indianapolis, IN
Residency St. Vincent Hospital and Health Services, Indianapolis, IN
Fellowship The University of Iowa Hospitals and Clinics, Iowa City, IA

Certifications

American Board of Obstetrics and Gynecology


Department Leadership Role

Director, Division of Gynecologic Oncology

Director, Fellowship in Gynecologic Oncology


Honors and Awards

America’s Top Doctors - Castle Connolly Medical Ltd.
 
“Top Doctors in Madison” - Madison Magazine
 
Invited Gyn Onc Oral Board Examiner - American Board of Obstetrics and Gynecology
 
Liz Tilberis Scholars Award from the Ovarian Cancer Research Foundation


Memberships

Society of Gynecologic Oncology Full Member

Fellow of the American College of Obstetrics and Gynecology

American Gynecological and Obstetrical Society Fellow

Gynecologic Oncology Group/NRG


Dr. Rose's Research

Research Focus: Quality of life issues for gynecologic cancer patients, gynecologic cancer survivorship, and basic and translational science research of gynecologic cancers.


Rose and patient featured in 2022 Sparkle of Hope grateful patient story

Ten years ago, avid Wisconsin Badgers football fan Shirley Pokorski received a gynecologic cancer diagnosis that put her tailgating traditions in peril. After working with UW Ob-Gyn Division of Gynecologic Oncology Director Steve Rose, MD, and an incredible care team at the UW Carbone Cancer Center, Shirley has been cancer-free and back at the field for years.

On WISC-TV News, Rose discussed Shirley’s treatment journey, and Shirley shared gratitude for her support system, including Rose and the Carbone team. Watch Shirley’s whole story here, and join us at Sparkle of Hope on September 16, 2022 to celebrate survivors like Shirley and the whole gynecologic cancer community! Learn more about how to join us at sparkleofhope.org.


Rose’s patient profiled by UW Carbone Cancer Center

In a new profile published by UW Health and the UW Carbone Cancer Center, a grateful patient who worked with Professor Stephen Rose, MD, director of the UW Ob-Gyn Division of Gynecologic Oncology, shared her cervical cancer treatment story.

In “A Remarkable Outcome”, Rose and patient Phyllis Stokes share her clinical experiences with cervical cancer and multiple treatment modalities. After less-than-ideal results with chemotherapy, Rose recommended Phyllis start immunotherapy treatment. What happened next was remarkable:

“Rose said her response was even better than he expected. Prior to the advent of immunotherapy, the average lifespan of someone diagnosed with stage IV cervical cancer was about a year. And even though immunotherapy has been a significant advancement in treatment, it’s still not a guarantee.

“Even being PD-L1 positive, many patients still don’t have a response to pembrolizumab,” he said. “For her to have those treatments for two years and then have no evidence of cancer anywhere is just remarkable.””

You can read the whole story here. Join the Department of Ob-Gyn and Division of Gynecologic Oncology at the 2022 Sparkle of Hope Gala on September 16 to celebrate the entire gynecologic cancer community, including remarkable patients like Phyllis!


Wang published in Gynecologic Oncology Reports

UW Ob-Gyn resident Connor Wang, MD is lead author on a new article published in Gynecologic Oncology Reports! Wang’s mentor on this project (and senior author on the publication) is UW Ob-Gyn Division of Gyencologic Oncology Director Steve Rose, MD.

Adaptive and maladaptive humor styles are closely associated with burnout and professional fulfillment in members of the Society of Gynecologic Oncology” used a survey of members of the Society of Gynecologic Oncology to assess individual humor styles and their connection to burnout. Humor styles (including adaptive styles and maladaptive styles) were assessed using the validated Humor Styles Questionnaire, and professional fulfillment (PF) and burnout (BO) were assessed using the Professional Fulfillment Index. The study examined responses from faculty, advanced practice providers, fellows, and residents:

“Clinically, our findings suggest the possibility of humor-based interventions to address BO and improve PF in SGO members. Humor-based interventions could be humor-based positive psychology interventions (PPIs) or workshops. Humor-based PPIs can enhance psychological and emotional wellbeing, life satisfaction, mood, and lower depressive feelings. (Wellenzohn et al., 2018) They can also increase participants’ sense of humor. (Wellenzohn et al., 2018)…Our results further indicated that trainees were more likely than faculty and APP to employ aggressive and self-defeating humors, and trainees experienced significantly lower PF than did faculty. Therefore, trainees may benefit most from humor-based interventions.”

Read the whole study here.


UW Ob-Gyn research and presentations at 2022 ACOG Annual Meeting

The American College of Obstetricians and Gynecologists held the Annual Clinical and Scientific Meeting in San Diego May 6-8, 2022. Faculty, fellows and residents in the UW Department of Ob-Gyn brought many exciting presentations and projects to the conference. Read more about some of their awesome accomplishments:

Division of Academic Specialists in Ob-Gyn Director Makeba Williams, MD gave the Morton and Diane Stenchever Lecture “The Women’s Health Initiative: Controversy, Confusion, Consensus” at the opening of the day on May 8: 

“In 2022, is hormone therapy safe? Have we reached a point of consensus? The Women’s Health Initiative hormone therapy trial preliminary results were released summer 2002, completely altering the practice of prescribing hormone therapy to midlife and menopausal women. Controversy and confusion immediately ensued. Attend this thought-provoking session to better understand current recommendations, management strategies and treatment options for menopausal patients.”

Division of Gynecologic Oncology Director Stephen Rose, MD, presented “A Revised Markov Model Evaluating Oophorectomy at the Time of Hysterectomy for Benign Indication”, co-authored by Gynecologic Oncology Fellow Shannon Rush, MD, during a late-breaking abstracts session on May 8.

More posters and presentations:

Black Women With Low Numeracy Fare Worse in Diabetic Pregnancies - Jennifer Jacobson, MD; Amy Godecker, PhD; Jennifer Janik, MD; April Eddy, MS; Jacquelyn Adams, MD

Assessment of In-Hospital Pain Control After Childbirth and Its Correlation With Anxiety in the Postpartum Period – Clara Olson, BS; John Poehlmann, MD; Zachary Stowe, MD; Kathleen Antony, MD

Clinical Application of a Previously Validated Pregnancy-Specific Screening Tool for Sleep Apnea – Kathleen Antony, MD

Operationalizing Aspirin to Reduce Preeclampsia Risk and Related Morbidity and Mortality – Maya Gross, MD; Katherine Sampene, MD

Leveraging Quality Improvement to Promote Health Equity: Prenatal Aspirin Recommendations by Race - Maya Gross, MD; Katherine Sampene, MD

In the Eye of the Beholder: Perspectives of Fellowship Applicants on Virtual Interviews - Christine Heisler, MD

Cost-Effectiveness of Opportunistic Salpingectomy Following Vaginal Delivery for Ovarian Cancer Prevention – Matthew Wagar, MD; Makeba Williams, MD

Incredible work, all!


UW Ob-Gyn presentations at 2022 Society of Gynecologic Oncology conference

Members of the UW Ob-Gyn Division of Gynecologic Oncology, fellows and residents prepared an impressive slate of posters and presentations for the 2022 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer! Take a look at just some of the research brought to the hybrid conference, as well as the variety of service and leadership roles held by members of our department:

Ahmed Al-Niaimi, MD:

Master Class: Optimize and Operate: Enhancing Perioperative Quality, Safety, Experience, and Outcomes

Master Class: Debulk and Deliver: A Virtual Live-Streamed Master Class with Optional Hands-On Cytoreductive Surgery Lab 

Oral Plenary Presentation: Mechanical bowel preparation and post-operative renal dysfunction in patients undergoing cytoreductive surgery for ovarian cancer

Lisa Barroilhet, MD, MS:

Distillation: On-Demand Oral Featured Posters: Novel Therapies, PROs, and Disparities in Care

Special Interest Session: Curriculum for Emerging Clinical Trialists (Dr. Barroilhet is course director for this session)

Vice-Chair of the Patient Education Committee

Katherine Dryer, MD:

Poster: Outpatient palliative care utilization and aggressiveness of end-of-life care in women with gynecologic cancers (authors Kathryn Dryer MD, Janelle Sobecki MD, Michael Lasarev MS, Lena Law BA, Anna Stecher MD, Ellen Hartenbach MD)

Maya Gross, MD, MPH:

Poster: Risk factors associated with distress among postoperative patients in an academic gynecologic oncology practice

Ellen Hartenbach, MD:

Symposium: Wake to Wellness: Beating Burnout Through Better Patient Communication (Hartenbach presented “Mitigating Burnout Through Effective Communication Techniques”)

Palliative Medicine Committee 

Clinical Practice Committee

David Kushner, MD:

Finance Committee

Wellness Committee (Chair)

Developed two “Wake to Wellness” Sessions based on SGO Wellness Curriculum that was just published:

Managing Priorities 

Moving from Surviving to Thriving (Kushner will present as part of this session)

Senior author on Surgical Innovation presentation “Beneath the Surface: Fluorescein mapping in vulvar Paget’s Disease” given by Gyn Onc fellow Catherine Zhang, MD

Joanne Rash, PA:

Attending the SGO Board meeting (virtually), and will start her board term as the first-ever APP representative on the SGO board

Stephen Rose, MD:

Co-Chair of the Fellowship Program Directors Network and will be leading the annual meeting Thursday night. 

Hosting the UW Fellow Alumni Reception Sunday night

Senior author on Connor Wang’s study: Adaptive and maladaptive humor styles are closely associated with burnout and professional fulfillment in members of the Society of Gynecologic Oncology

Shannon Rush, MD:

Poster: Hormone replacement therapy counseling at prophylactic bilateral salpingo-oophorectomy in high risk patients

Janelle Sobecki, MD:

Poster: Risk factors associated with distress among postoperative patients in an academic gynecologic oncology practice (Maya Gross, Sumer Wallace - Senior)

Poster: Outpatient Palliative Care Utilization and Aggressiveness of End-of-Life Care in Women with Gynecologic Cancers (Kathryn Dryer, Ellen Hartenbach – Senior)

Sumer Wallace, MD:

Serves on Policy, Quality, & Outcomes task force for the Health Policy and Socioeconomic committee

Connor Wang, MD:

Poster: Adaptive and maladaptive humor styles are closely associated with burnout and professional fulfillment in members of the Society of Gynecologic Oncology

Catherine Zhang, MD:

Poster: Thromboembolic events in gynecologic cancer patients treated with chemotherapy (authors R. Zhang, MD; T. Stewart, BS; K. Tetreault, MS; R. Alexandridis, PhD; J. Bergsbaken, PharmD;  S. Wallace, MD; D. Kushner, MD;E. Hartenbach, MD)

Farr Nezhat Session Surgical Innovation Session: How Surgical Futurists are Revolutionizing Cancer Care (Zhang presented “Beneath the Surface: Fluorescein mapping in vulvar Paget’s Disease”)

Congratulations to all for these incredible achievements!


Rush and Rose selected for late-breaking presentation at ACOG conference

Exciting news for UW Ob-Gyn Division of Gynecologic Oncology Director Stephen Rose, MD and gynecologic oncology fellow Shannon Rush, MD! Rose and Rush’s article “A Revised Markov Model Evaluating Oophorectomy at the Time of Benign Hysterectomy: Age 65 Years Revisited” was selected for the Obstetrics and Gynecology late-breaking research session at ACOG’s 2022 Annual Clinical and Scientific Meeting in San Diego, CA this May!

The editors of the journal Obstetrics and Gynecology selected four upcoming articles for presentation during this session based on their importance, innovation, and newsworthiness. Congratulations on this incredible honor!


Rose talks about gynecologic oncology as a practice on Specialty Stories podcast

On a recent episode of Specialty Stories, a podcast aimed at helping premed and medical students choose a future career, UW Ob-Gyn Division of Gynecologic Oncology Director Steve Rose, MD discussed what brought him to gynecologic oncology and what the subspecialty is like today.

During the conversation, Rose talked about key interests and traits that can lead to success in gynecologic oncology, the types of patients who work with gyn onc teams, what clinical and surgical schedules can look like, and other important information for medical students and ob-gyn residents considering a future career in gynecologic oncology.

Listen to the whole episode here


Rose discusses genetic testing for cancer with OncLive

In a recent installment of OncLiveTV, UW Ob-Gyn Division of Gynecologic Oncology Director Steve Rose, MD discussed the importance of genetic testing in ovarian cancer. 

In the video, Rose mentioned the importance of genetic testing in setting a treatment path for some ovarian cancers:

“The importance of the testing, for sure, has to do with the use of PARP inhibitors, specifically now that PARP inhibitors up front have been shown to be helpful in certain patients. And so making sure that you can get that ball rolling quickly and start talking to patients about whether or not they’re going to be eligible, dependent upon their BRCA either somatic or genetic status, and homologous recombination proficient or deficient status as well,” Rose says.

Rose also discusses current barriers to genetic testing in ovarian cancer patients. Watch the whole video here!


Rose selected as medical director for UW Health Regional Oncology Services

Congratulations to UW Ob-Gyn Gynecologic Oncology Division Director Steve Rose, MD! Rose was recently appointed to the role of Medical Director for Regional Oncology Services at UW Health.

In that role, Rose will be the physician leader for UW Health’s regional cancer program. Responsibilities include providing clinical and professional direction for the program; building relationships with regional leadership teams and referring providers; extending research opportunities to regional partners; and more. This role will also partner with the Regional Relations Medical Director for UW Health to ensure alignment across oncology specialties.   

Rose will work closely with all of UW Health’s cancer care regional affiliates to ensure that patients at these sites receive high-quality, cost-effective, remarkable care. This job is not specific to gynecologic oncology: Rose will provide leadership and direction for surgical cancer services, adult medical cancer services, radiation oncology cancer services, cancer imaging, and pediatrics cancer services.

Congratulations on this well-deserved honor, Dr Rose!


Mojdehbakhsh published in Gynecologic Oncology Reports

A quality improvement study by lead author Rachel Mojdehbakhsh, MD, PGY-2, was published in Gynecologic Oncology Reports. Co-authors include Stephen Rose, MD, Megan Peterson, DNP, Laurel Rice, MD, and Ryan Spencer, MD, all of the UW Ob-Gyn Division of Gynecologic Oncology.

In light of the COVID-19 pandemic that began in early 2020, industry organizations like the National Comprehensive Cancer Network recommended transitioning some appointments to telemedicine. Mojdehbakhsh’s study, “A quality improvement pathway to rapidly increase telemedicine services in a Gynecologic Oncology clinic during the COVID-19 pandemic with patient satisfaction scores and environmental impact”, outlines efforts at the UW Carbone Cancer Center’s gynecologic oncology clinic to move appointments to telehealth platforms over a short period of time. The study also assessed patient satisfaction with telemedicine visits, and environmental impact of moving visits online.

With multidisciplinary team planning and standardized note templates, transitioning 50% of encounters to telemedicine and achieving high rates of consent documentation were accomplished in four weeks. This increase in telemedicine represented a measurable decrease in the amount of CO  2 emissions. Additionally, patients were overwhelmingly satisfied.”

Read the whole study here – incredible work, Dr. Mojdehbakhsh and Gyn Onc division team!


First HAGO Conference was a great success!

On September 10-11, the UW Ob-Gyn Division of Gynecologic Oncology hosted the first-ever Heartland Association of Gynecologic Oncology (HAGO) meeting. More than 70 gynecologic oncology professionals tuned in for the virtual conference, which included two keynote presentations and 21 research abstract presentations.

HAGO was founded in 2020 by UW Ob-Gyn Division of Gyn Onc Director Stephen Rose, MD, and the program committee included Ryan Spencer, MD and UW Ob-Gyn Gyn Onc fellowship graduates Andrea O’Shea, MD and Shitanshu Uppal, MD.

Of the 21 abstracts selected for presentation, five were from our department (Matthew Wagar, MD with mentor Sumer Wallace, MDWagar with mentor Makeba Williams, MDShannon Rush, MD with mentor Steve Rose, MDRachel Mojdehbakhsh, MD with mentor Ryan Spencer, MD; and Connor Wang, MD with mentor Spencer).

UW Ob-Gyn Gyn Onc fellow Shannon Rush, MD earned the first Award for Clinical Research for her abstract “65 Revisited: A Revised Markov Model for Evaluating Oophorectomy at the Time of Hysterectomy for Benign Disease”!

Lisa Barroilhet, MD was also an invited distillation presenter and UW Ob-Gyn Department Chair Laurel Rice, MD gave a keynote address and received the inaugural HAGO Award for Service and Leadership.

Our congratulations to everyone involved in planning and preparing the HAGO Conference – incredible work!